Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.
about
The Impact of Anti-Epileptic Drugs on Growth and Bone MetabolismIon channels as drug targets in central nervous system disordersBisphenol A binds to the local anesthetic receptor site to block the human cardiac sodium channelNav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodentsLocating the route of entry and binding sites of benzocaine and phenytoin in a bacterial voltage gated sodium channelA quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels.Inhibition of neuronal voltage-gated sodium channels by brilliant blue GThe treatment of autism with low-dose phenytoin: a case report.Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.PharmGKB summary: phenytoin pathway.Probing kinetic drug binding mechanism in voltage-gated sodium ion channel: open state versus inactive state blockers.Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.Indoxacarb, Metaflumizone, and Other Sodium Channel Inhibitor Insecticides: Mechanism and Site of Action on Mammalian Voltage-Gated Sodium Channels.Sidedness of carbamazepine accessibility to voltage-gated sodium channels.The discovery and development of analgesics: new mechanisms, new modalities.Advances in targeting voltage-gated sodium channels with small molecules.Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes.Complex management of a patient with refractory primary erythromelalgia lacking a SCN9A mutation.A molecular model of the inner pore of the Ca channel in its open state.Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness.Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants.Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)1.7 mutant channel.Integrative chemical-biological read-across approach for chemical hazard classification.Structural Models of Ligand-Bound Sodium Channels.Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav 1.7 mutation I234T.Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents.New Anti-Seizure (Arylalkyl)azole Derivatives: Synthesis, In Vivo and In Silico Studies.Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.The efficacy of Ranolazine on E1784K is altered by temperature and calcium.Voltage-Gated Sodium Channels as Insecticide Targets.Docking, synthesis, and pharmacological evaluation of isoindoline derivatives as anticonvulsant agents
P2860
Q26739054-B7DACFA5-D9C1-4AE2-9052-9CA2DD99492EQ27004533-82B72776-54DE-4E00-8D21-CCE0018B514AQ27330612-9297CFBD-8553-4CA1-BD5E-81CA42A87941Q28235994-FC0F1BC5-42F1-4FFB-8EF7-8BC25AC150A8Q28540363-618CDB4E-00AC-4AA8-A8BB-F41C5040B5C1Q30486339-3B8593D6-A7F5-456F-A145-0323093F961DQ35084389-90340BFF-A993-4FBB-B0EC-E88182C11141Q35105194-2BBD109B-DF5C-4C2B-A6AB-2967B11864CEQ35122828-2B04406D-D1A3-443F-B8FC-74EFF20FCBCBQ35530114-09CB6143-047F-431E-A3EE-E91A02624BB2Q35664957-1A000775-CE94-4437-BCC5-68157C6E233AQ35950546-FFB83DE9-D8E7-4B03-8E5A-CA4A73C3FD02Q36782181-6FA08084-931D-4D91-8C09-B5E996B0A3E9Q36917811-DFD564B2-EF2D-4700-A611-955474CD0A4CQ37190744-75EA9687-DC0B-4F0F-8D14-E438247A2187Q37553511-6A6F8919-EAF6-43B8-88DB-0F5B5DDB744CQ37805995-0D3279F2-9BA5-4670-93C5-20B4CC64FE8AQ38040330-F8140B0C-935B-40D3-A1D7-3C98D3E2E9B2Q38093362-79413924-B7D6-4872-A03D-2E24C8411E6EQ39155847-35F5A051-6873-41F7-92D2-0837AD98AE15Q40646303-7B879B7E-4C9F-4FC8-8F41-D1584EE24E3EQ41687355-B03B5C5F-8AE7-4D36-A97E-B41F8A981BEAQ42056519-A8EDCBAC-CCD8-4D5D-87B7-3C3153324277Q42211742-30679B78-6D03-42CF-8C22-B3CE50D8DB45Q42921015-4C31FA38-F840-4B07-8C1B-8573B6FEF111Q47236925-5C1EC53C-0894-4E27-9CE7-EEF405FC4409Q47977892-41957168-1C21-4697-B86C-82E70E97D6C8Q48139074-BD630735-3C34-417A-9245-822A66296AA3Q48206344-DA1A3ACF-C462-4D1A-92BF-D2FFC174A304Q48822966-CB484CAB-90ED-45DD-AA17-43B9E776B4B8Q50348768-11102236-E2C3-425E-B661-04F617F78406Q55280224-4C1BEF76-A89A-4AAA-BE33-3E2017C5F1DCQ59285110-C4FED9DA-0CFD-4F53-A0CD-784608A53155
P2860
Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@ast
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@en
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@nl
type
label
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@ast
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@en
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@nl
prefLabel
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@ast
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@en
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@nl
P2860
P356
P1476
Molecular model of anticonvuls ...... ted sodium channel inner pore.
@en
P2093
Gregory M Lipkind
Harry A Fozzard
P2860
P304
P356
10.1124/MOL.110.064683
P577
2010-07-19T00:00:00Z